High Growth Tech Stocks In The UK October 2024

In the last week, the United Kingdom market has remained flat, although it has experienced a 12% increase over the past year, with earnings expected to grow by 14% annually. In this context of steady growth and positive forecasts, identifying high growth tech stocks involves looking for companies that demonstrate strong innovation potential and adaptability to capitalize on emerging opportunities within this dynamic sector.

Top 10 High Growth Tech Companies In The United Kingdom

Name	Revenue Growth	Earnings Growth	Growth Rating
Gaming Realms	11.57%	22.07%	★★★★★☆
STV Group	13.15%	46.78%	★★★★★☆
Altitude Group	23.46%	27.56%	★★★★★☆
Facilities by ADF	52.00%	144.70%	★★★★★☆
LungLife AI	100.61%	100.97%	★★★★★☆
Pinewood Technologies Group	20.07%	24.71%	★★★★★☆
Windar Photonics	63.60%	126.92%	★★★★★☆
Redcentric	4.89%	63.79%	★★★★★☆
Beeks Financial Cloud Group	22.12%	36.94%	★★★★★☆
Oxford Biomedica	21.02%	90.20%	★★★★★☆

Click here to see the full list of 47 stocks from our UK High Growth Tech and AI Stocks screener.

Let's review some notable picks from our screened stocks.

M&C Saatchi (AIM:SAA)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: M&C Saatchi plc is a global advertising and marketing communications company operating across the United Kingdom, Europe, the Middle East, Africa, the Asia Pacific, and the Americas with a market cap of £250.63 million.

Operations: M&C Saatchi generates revenue through its advertising and marketing communications services, focusing on creative solutions, media planning, and branding strategies across various regions. The company operates in diverse markets including the UK, Europe, the Middle East, Africa, Asia Pacific, and the Americas. Its cost structure primarily involves personnel expenses and operational costs related to delivering these services.

M&C Saatchi, transitioning through a pivotal year, has reversed its financial trajectory from a net loss of £6.38 million to a net income of £8.11 million as reported in the first half of 2024. This shift is underscored by an earnings growth forecast at an impressive 27.4% annually, outpacing the UK market average of 13.8%. However, challenges loom with expected revenue declines at -15.2% per year over the next three years, signaling potential headwinds in sustaining this growth momentum. The firm's commitment to innovation is evident from its R&D investments, crucial for staying competitive in the evolving advertising sector marked by digital transformation and shifting consumer behaviors.

• Unlock comprehensive insights into our analysis of M&C Saatchi stock in this health report.

• Review our historical performance report to gain insights into M&C Saatchi's's past performance.

Oxford Biomedica (LSE:OXB)

Simply Wall St Growth Rating: ★★★★★☆

Overview: Oxford Biomedica plc is a contract development and manufacturing organization specializing in delivering therapies globally, with a market cap of £468.85 million.

Operations: Oxford Biomedica generates revenue primarily through its Platform segment, which accounts for £97.24 million. The company focuses on the development and manufacturing of therapies for global distribution.

Oxford Biomedica is navigating through a transformative phase with a projected revenue growth of 21% annually, outstripping the UK market average of 3.6%. This surge is underpinned by anticipated earnings expansion at an impressive rate of 90.2% per year, signaling robust potential despite current unprofitability. The firm's commitment to innovation is evident in its R&D investments, aligning with industry trends toward advanced biotechnological solutions and potentially setting the stage for future profitability within three years. Recent leadership changes and reaffirmed financial guidance suggest strategic adjustments aimed at enhancing operational efficiency and market positioning.

• Click to explore a detailed breakdown of our findings in Oxford Biomedica's health report.

• Learn about Oxford Biomedica's historical performance.

Pinewood Technologies Group (LSE:PINE)

Simply Wall St Growth Rating: ★★★★★☆

Overview: Pinewood Technologies Group PLC is a cloud-based dealer management software provider serving the automotive industry both in the United Kingdom and internationally, with a market cap of £283.04 million.

Operations: The company generates revenue primarily from its software segment, amounting to £22.62 million. As a cloud-based dealer management software provider, it serves the automotive industry across the UK and internationally.

Pinewood Technologies Group is making significant strides in the UK tech sector, evidenced by a robust revenue growth forecast of 20.1% per year, notably outpacing the broader UK market's average of 3.6%. This growth trajectory is complemented by an anticipated earnings increase of 24.7% annually. The company's recent contract with Marshall Motor Group underscores its expanding influence and adoption across major dealership networks, promising deeper market penetration and enhanced operational scale which could be pivotal for its future positioning and performance in the competitive landscape.

• Click here to discover the nuances of Pinewood Technologies Group with our detailed analytical health report.

• Evaluate Pinewood Technologies Group's historical performance by accessing our past performance report.

Key Takeaways

• Get an in-depth perspective on all 47 UK High Growth Tech and AI Stocks by using our screener here.
• Already own these companies? Bring clarity to your investment decisions by linking up your portfolio with Simply Wall St, where you can monitor all the vital signs of your stocks effortlessly.
• Enhance your investing ability with the Simply Wall St app and enjoy free access to essential market intelligence spanning every continent.

Looking For Alternative Opportunities?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
• Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.
• Find companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com